This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (part of the National Institutes of Health) to Mattek Corporation, a small business manufacturer of human tissue models. The $98,259.02 contract is for the delivery of alveolar and tracheobronchial tissues in a ready-made format to support COVID-19 drug testing. The original solicitation was a total small business set-aside with a quick turnaround of 35 days for delivery to the NIH in...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Mattek Corporation, a for-profit manufacturer of human tissue models. The $20,802 contract is for the delivery of reconstructed human pigmented epidermis samples and maintenance media, to be completed by November 20, 2024. The contract has no set-aside designation. Mattek has a history of providing human tissue models to federal agencies like the National Institutes of Health (NIH), Centers for Disease...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Mattek Corporation, a for-profit manufacturer of human tissue models and assay kits. The $14,555.00 contract is for the delivery of Mattek's AMBIS #2231308 NASAL TISSUE MODEL AND EPINASAL ASSAY MEDIUM. This contract does not have a set-aside designation. Mattek has a history of providing human...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Mattek Corp, a foreign-owned for-profit manufacturer of human tissue models and assay kits. The $12,137 firm fixed-price purchase order is for the development of an NHBE (normal human bronchial epithelial) cell line using CRISPR/Cas or RNA interference (RNAi) technology. The contract has a small...
The Centers for Disease Control and Prevention, under the Department of Health and Human Services, has awarded a $248,907 purchase order to Mattek Corporation. This firm fixed price contract is to obtain human lung tissue matrix samples to characterize variants of SARS-CoV-2, the virus that causes COVID-19. Performance will take place in Chamblee, Georgia over a period of one year from August 2023 through August 2024. No set aside designation or subcontractors were indicated. The CDC works to...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research...
This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services (HHS), to Mimetas Operations US, Co., a foreign-owned, self-certified small disadvantaged business. The $150,480.00 contract is for the acquisition of Organoplate Grafts, which are microfluidic 3D cell culture plates used in scientific research projects related to SARS-CoV-2 and COVID-19. This contract was...
The Centers for Disease Control and Prevention (CDC) awarded Formlabs Inc. a $31,284.86 firm fixed price purchase order to procure 3D printers. As part of its mission to protect public health through health promotion, prevention of disease, injury and disability, the CDC will utilize the three-dimensional printers to support its research and development activities. Formlabs will deliver the printers to the CDC's Pittsburgh location by September 2024. No subcontractors or set aside designations...
This is a firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mimetas Operations US, CO. for 25 units of the Organoplate Graft (part number 6401-400-B), a microfluidic 3D cell culture plate used in research related to SARS-CoV-2 and COVID-19. The $29,075.00 contract was awarded on a sole-source, non-competitive basis due to...
The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...